https://www.selleckchem.com/pr....oducts/Vorinostat-sa
00 GP referrals). 3-year OS was 54% for both R-miniCHOP and R-CHOP in ≥80 years. Our comprehensive population analysis is the first to show that the NHS urgent cancer pathway is associated with a superior survival after adjusting for multiple confounders. Equivalent survival for R-CHOP and R-mini-CHOP was demonstrated in those ≥80 years. Our comprehensive population analysis is the first to show that the NHS urgent cancer pathway is associated with a superior survival after adjusting for multiple confounders. Equivalent survival
Like
Comment
Share
